SESANA, MARIA SILVIA
SESANA, MARIA SILVIA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells
2022 Delfanti, G; Cortesi, F; Perini, A; Antonini, G; Azzimonti, L; de Lalla, C; Garavaglia, C; Squadrito, M; Fedeli, M; Consonni, M; Sesana, S; Re, F; Shen, H; Dellabona, P; Casorati, G
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics
2022 Taiarol, L; Bigogno, C; Sesana, S; Kravicz, M; Viale, F; Pozzi, E; Monza, L; Carozzi, V; Meregalli, C; Valtorta, S; Moresco, R; Koch, M; Barbugian, F; Russo, L; Dondio, G; Steinkühler, C; Re, F
An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy
2020 Taiarol, L; Formicola, B; Magro, R; Sesana, S; Re, F
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide
2017 Gregori, M; Taylor, M; Salvati, E; Re, F; Mancini, S; Balducci, C; Forloni, G; Zambelli, V; Sesana, M; Michael, M; Michail, C; Tinker Mill, C; Kolosov, O; Scherer, M; Harris, S; Fullwood, N; Masserini, M; Allsop, D
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS
2016 Zoia, C; Conti, E; Cereda, D; RODRIGUEZ MENENDEZ, V; Andreoni, S; Gregori, M; Sesana, M; Masserini, M; Tremolizzo, L; Ferrarese, C
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes
2016 Gregori, M; Orlando, A; Re, F; Sesana, M; Nardo, L; Salerno, D; Mantegazza, F; Salvati, E; Zito, A; Malavasi, F; Masserini, M; Cazzaniga, E
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease
2015 Zoia, C; Conti, E; Ulisse, A; RODRIGUEZ MENENDEZ, V; Gregori, M; Sesana, M; Masserini, M; Ferrarese, C
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro
2015 Gregori, M; Bertani, D; Cazzaniga, E; Orlando, A; Mauri, M; Bianchi, A; Re, F; Sesana, M; Minniti, S; Francolini, M; Cagnotto, A; Salmona, M; Nardo, L; Salerno, D; Mantegazza, F; Masserini, M; Simonutti, R
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease
2014 Bana, L; Minniti, S; Salvati, E; Sesana, M; Zambelli, V; Cagnotto, A; Orlando, A; Cazzaniga, E; Zwart, R; Scheper, W; Masserini, M; Re, F
Role of lipid rafts and GM1 in the segregation and processing of Prion Protein
2014 Botto, L; Cunati, D; Coco, S; Sesana, M; Bulbarelli, A; Biasini, E; Colombo, L; Negro, A; Chiesa, R; Masserini, M; Palestini, P
Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages
2013 Orlando, A; Re, F; Sesana, M; Rivolta, I; Panariti, A; Brambilla, D; Nicolas, J; Couvreur, P; Andrieux, K; Masserini, M; Cazzaniga, E
Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model
2013 Re, F; Salvati, E; Sesana, M; Cambianica, I; Sancini, G; Masserini, M; Gregori, M
Liposomes functionalized with GT1b ganglioside with high affinity for amyloid beta-peptide
2012 Salvati, E; Masserini, M; Sesana, M; Sonnino, S; Re, F; Gregori, M
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue
2011 Canovi, M; Markoutsa, E; Lazar, A; Pampalakis, G; Clemente, C; Re, F; Sesana, M; Masserini, M; Salmona, M; Duyckaerts, C; Flores, O; Gobbi, M; Antimisiaris, S
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model
2011 Re, F; Cambianica, I; Zona, C; Sesana, M; Gregori, M; Rigolio, R; LA FERLA, B; Nicotra, F; Forloni, G; Cagnotto, A; Salmona, M; Masserini, M; Sancini, G
Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles
2011 Rivolta, I; Panariti, A; Lettiero, B; Sesana, M; Gasco, P; Gasco, M; Masserini, M; Miserocchi, G
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide
2011 Re, F; Cambianica, I; Sesana, M; Salvati, E; Cagnotto, A; Salmona, M; Couraud, P; Moghimi, S; Masserini, M; Sancini, G
Tat-1-liposomes to overcome the blood-brain barrier: an in vitro study
2010 Re, F; Cambianica, I; Sesana, M; Cagnotto, A; Salmona, M; Sancini, G
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide
2010 Gobbi, M; Re, F; Canovi, M; Beeg, M; Gregori, M; Sesana, M; Sonnino, S; Brogioli, D; Musicanti, C; Gasco, P; Salmona, M; Masserini, M
TrkA pathway activation induced by amyloid-beta (Abeta)
2009 Bulbarelli, A; Lonati, E; Cazzaniga, E; Re, F; Sesana, M; Barisani, D; Sancini, G; Mutoh, T; Masserini, M